Bionano (BNGO) CSO Alex Hastie Receives 54,000-Share Award

What Happened
Alex Reid Hastie, Chief Scientific Officer of Bionano Genomics (BNGO), was granted a derivative award for 54,000 shares on August 3, 2026. The award is reported at $0.00 per share (no cash paid at grant). This is an equity compensation grant (not a market purchase or sale).

Key Details

• Transaction date: 2026-08-03; reported on Form 4 filed 2026-08-05.
• Transaction type/code: A = Award/Grant (derivative security). Price reported: $0.00.
• Shares reported in this grant: 54,000 shares. The filing does not state total shares owned after the transaction.
• Footnote highlights:
  • Vesting: 25% of the shares vest Aug 2, 2027, then the remainder vests in 36 equal monthly installments thereafter, subject to continuous service. (F1)
  • Administrative note: This Form 4 replaces an erroneously filed Form 3 submitted Aug 5, 2026. (F2)
• Filing timeliness: Form 4 was submitted two days after the grant date and replaces the erroneous Form 3; no indication in the filing of a late reporting penalty.

Context
This is a standard compensation award intended for retention and future service — the shares are subject to a multi-year vesting schedule and are not immediately liquid. Because no cash changed hands at grant and vesting is delayed, the transaction doesn't represent an immediate buy or sell in the open market.